Sarepta Therapeutics Inc (SRPT)
130.02
+5.77
(+4.64%)
USD |
NASDAQ |
Apr 25, 12:32
Sarepta Therapeutics Profit Margin (Quarterly): 11.51% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 11.51% |
| September 30, 2023 | -12.34% |
| June 30, 2023 | -9.16% |
| March 31, 2023 | -203.8% |
| December 31, 2022 | -42.27% |
| September 30, 2022 | -111.9% |
| June 30, 2022 | -99.14% |
| March 31, 2022 | -49.82% |
| December 31, 2021 | -60.55% |
| September 30, 2021 | -25.42% |
| June 30, 2021 | -49.61% |
| March 31, 2021 | -113.8% |
| December 31, 2020 | -130.4% |
| September 30, 2020 | -136.5% |
| June 30, 2020 | -109.8% |
| March 31, 2020 | -15.39% |
| December 31, 2019 | -235.4% |
| September 30, 2019 | -127.5% |
| June 30, 2019 | -292.0% |
| March 31, 2019 | -88.08% |
| December 31, 2018 | -166.9% |
| September 30, 2018 | -97.33% |
| June 30, 2018 | -148.6% |
| March 31, 2018 | -54.74% |
| December 31, 2017 | -41.90% |
| Date | Value |
|---|---|
| September 30, 2017 | -103.9% |
| June 30, 2017 | -180.1% |
| March 31, 2017 | |
| December 31, 2016 | -1.63K% |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | -5.16K% |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | |
| December 31, 2014 | -164.5K% |
| September 30, 2014 | -2.76K% |
| June 30, 2014 | -1.31K% |
| March 31, 2014 | -464.4% |
| December 31, 2013 | -335.9% |
| September 30, 2013 | -1.01K% |
| June 30, 2013 | -645.6% |
| March 31, 2013 | -940.6% |
| December 31, 2012 | -846.1% |
| September 30, 2012 | -654.3% |
| June 30, 2012 | 71.72% |
| March 31, 2012 | -157.9% |
| December 31, 2011 | -10.38% |
| September 30, 2011 | -53.43% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-292.0%
Minimum
Jun 2019
11.51%
Maximum
Dec 2023
-95.45%
Average
-99.14%
Median
Jun 2022
Profit Margin (Quarterly) Benchmarks
| PTC Therapeutics Inc | -50.74% |
| Vertex Pharmaceuticals Inc | 38.48% |
| Regenxbio Inc | -283.1% |
| CytomX Therapeutics Inc | 3.15% |
| Apellis Pharmaceuticals Inc | -60.51% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -77.39% |
| Return on Assets | -17.08% |
| Return on Invested Capital | -26.93% |
| Gross Profit Margin (Quarterly) | 88.87% |
| Operating Margin (Quarterly) | 6.21% |
| Return on Net Operating Assets | -54.08% |